| abstract |
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof:n n n Formula In n n n n n n n Wheren n n Ar, Ar 2 , R 2 , R 3 , R 4 , m, p and s are as defined in the above description and claims.n n n The compounds are useful for the treatment and / or prevention of diseases associated with the activation of glycogen synthase enzymes, for example diabetes. |